ACUTE PHARMACOKINETIC AND HEMODYNAMIC-EFFECTS OF INTRAVENOUS BOLUS DOSING OF NICARDIPINE

被引:30
作者
CHEUNG, DG [1 ]
GASSTER, JL [1 ]
NEUTEL, JM [1 ]
WEBER, MA [1 ]
机构
[1] VET ADM MED CTR,CTR HYPERTENS,5901 E 7TH ST,LONG BEACH,CA 90822
关键词
D O I
10.1016/S0002-8703(05)80065-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antihypertensive effects, duration of action, and pharmacokinetics of intravenous bolus doses of nicardipine were investigated in a series of patients with mild-to-moderate hypertension. Patients with a supine diastolic blood pressure between 95 and 114 mm Hg and a heart rate<90 beats/min who received no other antihypertensive medications were included in the study. On separate study days, single intravenous bolus doses of 0.125, 0.25, 0.5, 1, 3, 5, and 7 mg of nicardipine were administered over a 2-minute period. Blood pressure and heart rate were measured for 6 hours after an intravenous bolus of nicardipine was given, and serum nicardipine levels were measured throughout the study. Although the antihypertensive effect occurred immediately during the bolus infusion, peak average decreases in systolic and diastolic pressure ranged from 20 to 25 and 15 to 44 mm Hg, respectively, and occurred 2.5±0.6 minutes after infusion. Heart rate increased by 12 to 40 beats/min during the peak effect. The mean duration of action after an intravenous bolus dose was 24±5 minutes. A dose-response relationship was observed, as both nicardipine dosage and plasma nicardipine concentration correlated with reduction in blood pressure. These data indicate that bolus administration of nicardipine may provide a practical approach for the rapid parenteral treatment of hypertensive states. © 1990.
引用
收藏
页码:438 / 442
页数:5
相关论文
共 16 条
[1]   NICARDIPINE IN MODELS OF MYOCARDIAL-INFARCTION [J].
ALPS, BJ ;
CALDER, C ;
WILSON, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 :S29-S49
[2]  
AOKO K, 1985, J CARDIOVASC PHAR S4, V7, pS28
[3]  
Cochran W.G, 1957, STAT METHODS, V6th ed
[4]  
GAAB MR, 1985, BR J CLIN PHARM, pS67
[5]   SHORT-TERM AND LONG-TERM TREATMENT OF STABLE EFFORT ANGINA WITH NICARDIPINE, A NEW CALCIUM-CHANNEL BLOCKER - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, REPEATED CROSSOVER STUDY [J].
GHEORGHIADE, M ;
STCLAIR, C ;
STCLAIR, J ;
FREEDMAN, D ;
SCHWEMER, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 :S195-S205
[6]  
GILL JS, 1985, LANCET, V1, P567
[7]  
IWAMANI M, 1979, CHEM PHARM BULL, V27, P1426
[8]   SHORT-TERM AND LONG-TERM EFFICACY OF NICARDIPINE, ASSESSED BY PLACEBO-CONTROLLED SINGLE-BLIND AND DOUBLE-BLIND CROSSOVER TRIALS IN PATIENTS WITH CHRONIC STABLE ANGINA [J].
KHURMI, NS ;
BOWLES, MJ ;
SUBRAMANIAN, VB ;
RAFTERY, EB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 4 (05) :908-917
[9]   HEMODYNAMIC-EFFECTS OF NICARDIPINE HYDROCHLORIDE - STUDIES DURING ITS USE TO CONTROL ACUTE HYPERTENSION IN ANESTHETIZED PATIENTS [J].
KISHI, Y ;
OKUMURA, F ;
FURUYA, H .
BRITISH JOURNAL OF ANAESTHESIA, 1984, 56 (09) :1003-1007
[10]  
LAHIRI A, 1984, POSTGRAD MED J, V60, P35